Andrew Marks
Jump to navigation
Jump to search
Andrew Robert Marks (born February 22, 1955), is an American cardiologist and molecular biologist. He is Professor and Chair of the Department of Physiology and Cellular Biophysics at Columbia University College of Physicians and Surgeons, Founding Director of the Clyde and Helen Wu Center for Molecular Cardiology,[1] and a Wu Professor of Medicine.
Marks developed the first drug-eluting stent coated with rapamycin in an effort to reduce fatty plaque buildup on the stent material itself.[2]
References
- ^ "Andrew R. Marks, MD". columbia.edu. Columbia University. Retrieved 30 August 2016.
- ^ "Andrew Marks". www.heart.org. 22 June 2010. Retrieved 21 September 2019.
External links
| International | |
|---|---|
| National | |
| Other | |
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles with ISNI identifiers
- Articles with VIAF identifiers
- Articles with BIBSYS identifiers
- Articles with J9U identifiers
- Articles with LCCN identifiers
- Articles with NTA identifiers
- Articles with SUDOC identifiers
- 1955 births
- American cardiologists
- American molecular biologists
- Columbia University faculty
- Amherst College alumni
- Icahn School of Medicine at Mount Sinai faculty
- Living people
- Journal of Clinical Investigation editors
- Members of the National Academy of Medicine